Replies to post #20836 on Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

DCMAN GREAT POST and DD

Wolf Says
This contradicts everything others have been posting. They claimed that there were no patents..That there are no combinations of bio markers between DR70 and BT and other tests that William has patented..

dcspka Thursday, 04/17/14 10:28:08 AM
Re: dcspka post# 20836
Post # of 20844
BT Test??? RCP Test???

From an earlier press release:

"RCP Diagnostics(TM) announced today that they have entered into a licensing agreement with Biomarker Technologies to allow Biomarker to use RCP's protein marker, riboflavin carrier protein, in conjunction with Biomarker's blood diagnostic for breast cancer, called the BT Test(TM).

The BT Test is a patented blood test that looks at five important cancer associated biomarkers, which, when analyzed in combination with each other and evaluated using the Company's proprietary data processing protocol, has demonstrated a capability of detecting breast cancer better than either digital or film mammography. Biomarker Technologies launched its second clinical study the week of April 23rd, which will involve more than 930 women and is expected to take four to six months to complete.

RCP's President, William Gartner said, "Due to the high sensitivity and the early stage differentiation of breast cancer demonstrated by RCP, Biomarker Technologies is investigating the incorporation of this marker into their latest clinical study as a potential contributor to the BT Test's panel of markers. We will be evaluating RCP both as an independent marker and as a synergistic component to the BT Test." Under the terms of the agreement, Biomarker will use the RCP marker only for the diagnosis of breast cancer.

Hmm - where is this now?

Wolf Says

They are within our grasp..That is where they are DC Man..Wolf

What I find interesting from the 2010 LOI announcement:

" Provista Diagnostics Inc. is a healthcare and biotechnology development company located in Phoenix, Arizona, that provides innovative tests for early disease detection to medical professionals and patients. The Company's product portfolio includes:

BT Test® - a diagnostic blood test that detects and measures the levels of key biomarkers that are associated with breast cancer.
LymPro Test® - a blood test designed to work with traditional diagnostic methods to assist doctors in a more timely and accurate diagnosis of Alzheimer's disease.
RCP Test® - a diagnostic blood test for the possible presence of ovarian, uterine, and cervical cancer in women.
REDx™ - a diagnostic blood test to screen for Mild Cognitive Impairment, Alzheimer's disease and other forms of dementia."

We know that LymPro was licensed to Amarantus courtesy of William Gartner.

BT test??? RCP Test??? REDx ???